EAEvelina Georgieva Atanasova

Evelina Georgieva Atanasova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evelina Georgieva Atanasova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pancreatic cancer liver metastasis mimicking focal nodular hyperplasia. A case report.

    by Oliver Wedel Fischer, Tobias Freyberg Justesen, Christian Pallson Nolsøe, Christo Pentchev Pentchev, Evelina Georgieva Atanasova

    Metastases to the liver from gastroenteropancreatic neuroendocrine tumors are varied in their presentation and echogenicity on ultrasound. We present a case of adenocarcinoma of the pancreas with sporadic neuroendocrine differentiation and metastasis to the liver, referred for inclusion in a clinical study. Standard ultrasound showed two hypoechoic focal liver lesions. On contrast enhanced ultrasound (CEUS) the larger tumour bore an enhancement resemblance to that of a focal nodular hyperplasia (FNH). This result necessitated a histological confirmation, which indicated neuroendocrine, highly differentiated tumour tissue, compatible with metastasis from the patient’s pancreatic cancer. This case showcases the role of histologically confirmed diagnosis in liver lesions with atypical imaging characteristics, especially in patients with a history of malignancy and potential oncological treatment.

  • Open Access

    Intracavitary Applications for CEUS in PTCD

    by Evelina G. Atanasova, Christo P. Pentchev, Christian P. Nolsøe

    Intracavitary contrast-enhanced ultrasound is widely accepted as a highly informative, safe, and easily reproducible technique for the diagnosis, treatment, and follow-up of different pathologies of the biliary tree. This review article describes the diverse applications for CEUS in intracavitary biliary scenarios, supported by a literature review of the utilization of the method in indications like biliary obstruction by various etiologies, including postoperative strictures, evaluation of the biliary tree of liver donors, and evaluation of the localization of a drainage catheter. We also provide pictorial examples of the authors’ personal experience with the use of intracavitary CEUS in cases of PTCD as a palliative intervention. Intracavitary CEUS brings all the positive features of US together with the virtues of contrast-enhanced imaging, providing comparable accuracy to the standard techniques for diagnosing biliary tree diseases.


  • Open Access

    Intracavitary Applications for CEUS in PTCD

    by Evelina Georgieva Atanasova, Christo Pentchev Pentchev, Christian Pállson Nolsøe

    Background: Intracavitary contrast-enhanced ultrasound is widely accepted as a highly informative, safe and easily reproducible technique for diagnosis, treatment and follow- up of different pathologies of the biliary tree. Methods: This article reports the combined conclusions of personal experience with pictorial examples and literature review of applications for CEUS in intracavitary biliary scenarios. Different methodologies, choices of equipment, indications for the procedure and expected complications were identified and described from the authors’ own experience as well as from a review of published studies with total of 208 patients for the period between 2009 and 2015. Results: Indications were biliary obstruction by various etiologies, including postoperative strictures, evaluation of the biliary tree of liver donors (n=12) and evaluation of localization of a drainage catheter. One of the studies found a statistically significant difference in the diagnostic accuracy of PTC and PUSC. Conclusion: Intracavitary CEUS brings all the positive features of US together with the virtues of contrast- enhanced imaging, proving comparable accuracy to the listed techniques for diagnostics of biliary tree diseases.

  • Open Access

    Renal cell carcinoma presented with a rare case of icteric Stauffer syndrome: A case report

    by Dimitar R Popov, Krasimir A Antonov, Evelina G Atanasova, Christo P Pentchev, Lyuben M Milatchkov, Maria D Petkova, Krasimir G Neykov, Rosen K Nikolov

    Paraneoplastic syndromes remain poorly understood and manifest as multifaceted clinical symptoms, making their diagnosis difficult. Cholestasis can be observed in various malignancies. In rare cases, it can be a paraneoplastic manifestation, most often associated with renal cell carcinoma and other urogenital tumors, as well as with bronchial carcinoma. The classical form of Stauffer syndrome presents with a reversible anicteric increase of cholestatic liver function tests, thrombocytosis, coagulation impairment, and hepatosplenomegaly, without any proven hepatobiliary obstruction or metastases. We report a patient who presented with elevated liver enzymes, cholestatic jaundice, weight loss and pruritus, in whom renal cell carcinoma was incidentally found during hospitalization. Clinical, laboratory, and imaging tests excluded primary hepatic cause or metastatic disease. Jaundice and laboratory abnor malities reversed completely a few months after nephrectomy. This case is an example of the many sides of renal cell carcinoma, and it focuses the clinicians’ attention on the differential diagnosis of cholestasis, including Stauffer syndrome and its variant. Thus, the correct diagnosis can be straightforward and the associated malignancy can be treated promptly. All cases should be followed up with a multidisciplinary team. Interleukin (IL)-6 is proposed to contribute to the pathophysiology of the condition. The probable mechanism is proinflammatory activity by the IL-6 cytokine, causing elevation of C-reactive protein and haptoglobin and inhibition of hepatobiliary transporter gene expression, impairing biliary outflow. Despite being rare, Stauffer syndrome is a potentially reversible paraneoplastic condition, when the primary cause is treatable. This syndrome should be considered by clinicians because of the remediable liver disturbance, after successful treatment of the underlying malignancy.